参考文献/References:
[1]国家心血管病中心,中国心血管健康与疾病报告编写组,胡盛寿.中国心血管健康与疾病报告2023概要[J].中国循环杂志,2024,39(7):625-660.
[2]BAMAN J R,AHMAD F S.Heart failure[J].JAMA,2020,324(10):1015.
[3]FULSTER S,TACKE M,SANDEK A,et al.Muscle wasting in patients with chronic heart failure:Results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)[J].Eur Heart J,2013,34(7):512-519.
[4]SARKOZY M,KOVACS Z,KOVACS M G,et al.Mechanisms and modulation of oxidative/nitrative stress in type 4 cardio-renal syndrome and renal sarcopenia[J].Front Physiol,2018,9:1648.
[5]PICCA A,MANKOWSKI R T,BURMAN J L,et al.Mitochondrial quality control mechanisms as molecular targets in cardiac ageing[J].Nat Rev Cardiol,2018,15(9):543-554.
[6]XU Z,FU T,GUO Q,et al.Disuse-associated loss of the protease LONP1 in muscle impairs mitochondrial function and causes reduced skeletal muscle mass and strength[J].Nat Commun,2022,13(1):894.
[7]CRUZ-JENTOFT A J,SAYER A A.Sarcopenia[J].Lancet,2019,393(10191):2636-2646.
[8]戴娜,何兰,胡晶,等.“脾主肌肉”的理论探讨及其临床意义[J].中医杂志,2018,59(2):95-99.
[9]EMERY A E.The muscular dystrophies[J].Lancet,2002,359(9307):687-695.
[10]DELMONICO M J,Harris T B,Visser M,et al.Longitudinal study of muscle strength,quality,and adipose tissue infiltration[J].Am J Clin Nutr,2009,90(6):1579-1585.
[11]BOARDMAN N T,TRANI G,SCALABRIN M,et al.Intracellular to interorgan mitochondrial communication in striated muscle in health and disease[J].Endocr Rev,2023,44(4):668-692.
[12]PALIKARAS K,LIONAKI E,TAVERNARAKIS N.Mechanisms of mitophagy in cellular homeostasis,physiology and pathology[J].Nat Cell Biol,2018,20(9):1013-1022.
[13]ONISHI M,YAMANO K,SATO M,et al.Molecular mechanisms and physiological functions of mitophagy[J].EMBO J,2021,40(3):e104705.
[14]GOFFART S,VON KLEIST R J,WIESNER R J.Regulation of mitochondrial proliferation in the heart:Power-plant failure contributes to cardiac failure in hypertrophy[J].Cardiovasc Res,2004,64(2):198-207.
[15]DEMONTIS F,PERRIMON N.FOXO/4E-BP signaling in drosophila muscles regulates organism-wide proteostasis during aging[J].Cell,2010,143(5):813-825.
[16]KWAK J Y,HWANG H,KIM S K,et al.Prediction of sarcopenia using a combination of multiple serum biomarkers[J].Sci Rep,2018,8(1):8574.
[17]POPOV L D.Mitochondrial biogenesis:An update[J].J Cell Mol Med,2020,24(9):4892-4899.
[18]RODGERS J T,LERIN C,HAAS W,et al.Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1[J].Nature,2005,434(7029):113-118.
[19]WANG J,LI S,WANG J,et al.Spermidine alleviates cardiac aging by improving mitochondrial biogenesis and function[J].Aging (Albany NY),2020,12(1):650-671.
[20]KOLTAI E,HART N,TAYLOR A W,et al.Age-associated declines in mitochondrial biogenesis and protein quality control factors are minimized by exercise training[J].Am J Physiol Regul Integr Comp Physiol,2012,303(2):127-134.
[21]SAFDAR A,HAMADEH M J,KACZOR J J,et al.Aberrant mitochondrial homeostasis in the skeletal muscle of sedentary older adults[J].PLoS One,2010,5(5):e10778.
[22]FORTE M,SCHIRONE L,AMERI P,et al.The role of mitochondrial dynamics in cardiovascular diseases[J].Br J Pharmacol,2021,178(10):2060-2076.
[23]DIWAN A.Preserving mitochondria to treat hypertrophic cardiomyopathy: From rare mitochondrial DNA mutation to heart failure therapy?[J].J Clin Invest,2023,133(14):e171965.
[24]JIN J Y,WEI X X,ZHI X L,et al.Drp1-dependent mitochondrial fission in cardiovascular disease[J].Acta Pharmacol Sin,2021,42(5):655-664.
[25]ZHOU H,WANG J,ZHU P,et al.NR4A1 aggravates the cardiac microvascular ischemia reperfusion injury through suppressing FUNDC1-mediated mitophagy and promoting Mff-required mitochondrial fission by CK2α[J].Basic Res Cardiol,2018,113(4):23.
[26]DORN G N,SONG M,WALSH K.Functional implications of mitofusin 2-mediated mitochondrial-SR tethering[J].J Mol Cell Cardiol,2015,78(9):123-128.
[27]IBEBUNJO C,CHICK J M,KENDALL T,et al.Genomic and proteomic profiling reveals reduced mitochondrial function and disruption of the neuromuscular junction driving rat sarcopenia[J].Mol Cell Biol,2013,33(2):194-212.
[28]MONGRAW C M,FOSTER M C,ANDERSON C,et al.Metabolically healthy obesity,transition to metabolic syndrome,and cardiovascular risk[J].J Am Coll Cardiol,2018,71(17):1857-1865.
[29]WEST A P,SHADEL G S,GHOSH S.Mitochondria in innate immune responses[J].Nat Rev Immunol,2011,11(6):389-402.
[30]刘友章,宋雅芳,劳绍贤,等.胃脘痛患者胃黏膜超微结构研究及中医“脾-线粒体相关”理论探讨[J].中华中医药学刊,2007,25(12):2439-2442.
[31]刘劲,曲长江.三种脾虚模型小鼠线粒体超微结构改变的比较研究[J].中医药学刊,2001，14(4):378-379.
[32]任欣伟,张卫国,聂玉真.黄芪甲苷通过CaMkkβ/AMPK通路对急性心力衰竭大鼠心肌细胞线粒体自噬的作用机制研究[J].医药论坛杂志,2023,44(9):41-46.
[33]夏冉.基于线粒体质量控制探究艾灸治疗气虚血瘀型慢性心力衰竭的机制及临床疗效观察[D].合肥：安徽中医药大学,2022.
[34]谢凌云,刘馨烛,夏瑜彬,等.黄芪汤对慢性胆汁淤积继发肌少症大鼠骨骼肌细胞线粒体损伤的影响[J].中华中医药杂志,2024,39(1):139-146.
[35]姚娟,丁芮,李向阳,等.苓桂术甘汤对心梗后慢性心衰大鼠线粒体分裂-融合及Sirt3/AMPK信号通路的影响[J].中国实验方剂学杂志,2024,30(3):1-9.
[36]宋玉莹,崔琳,何玉凤,等.参附益心颗粒对心肌梗死后心力衰竭大鼠线粒体动力学的影响[J].中国实验方剂学杂志,2024,30 (11):87-94.
[37]勇入琳,董佳梓,张立德,等.电针“足三里”对脾气虚大鼠骨骼肌组织超微结构及线粒体动力学的影响[J].针刺研究,2020,45(1):15-20.
[38]朱海燕,万李,丁若兰,等.基于线粒体动力学失衡探讨参芪复方含药血清对高糖诱导的骨骼肌细胞线粒体损伤的改善作用[J].中药材,2022,45(11):2719-2725.
[39]陈翊,林凯旋,李雪山,等.益气温阳逐水方通过调控水通道蛋白和心肌能量代谢改善心力衰竭的作用及机制研究[J].中华中医药学刊,2023,41(10):48-52.
[40]董佳梓,张妤,魏云涛,等.电针“足三里”对脾虚大鼠骨骼肌线粒体自噬相关蛋白表达的影响[J].中国针灸,2018,38(7):741-746.
相似文献/References:
[1]杨禹娟,张勇,吕军,等.益气复脉注射液治疗老年冠心病并发慢性心力衰竭30例[J].陕西中医,2016,(10):1325.
Yang Yujuan,Zhang Yong,Lv Jun,et al.[J].,2016,(6):1325.
[2]任红杰,赵安社,安谊沛,等.芪苈强心胶囊联合西药治疗慢性心力衰竭疗效及对患者NT-proBNP、hs-CRP、VEGF的影响*[J].陕西中医,2019,(6):711.
[3]隋艳波,凌丽云,刘 莉.“血不利则为水”理论论治心力衰竭研究[J].陕西中医,2021,(2):213.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.019]
SUI Yanbo,LING Liyun,LIU Li.Treating heart failure based on the theory of “Unsmooth blood circulation results in water”[J].,2021,(6):213.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.019]
[4]陈仁山,肖惠珍,刘 宁,等.参芪扶正注射液抑制ERK1/2、GATA4信号通路改善小鼠心力衰竭实验研究[J].陕西中医,2022,(1):8.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.002]
CHEN Renshan,XIAO Huizhen,LIU Ning,et al.Effect of Shenqi Fuzheng injection on heart failure in mice by inhibiting ERK1/2,GATA4 signaling pathway[J].,2022,(6):8.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.002]
[5]尼苦王康,邓 兵.中药治疗射血分数保留的心力衰竭研究进展[J].陕西中医,2022,(3):405.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.033]
NiKU Wangkang,DENG Bing.Research progress of traditional Chinese medicine in treating heart failure with preserved ejection fraction[J].,2022,(6):405.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.033]
[6]寇林利,赵明君,魏明明,等.苓桂术甘汤对慢性心力衰竭大鼠心肌功能及心室重构的影响[J].陕西中医,2022,(9):1170.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.004]
KOU Linli,ZHAO Mingjun,WEI Mingming,et al.Effect on improvement of myocardial function and ventricular remodeling in rats with chronic heart failure by Linggui Zhugan decoction[J].,2022,(6):1170.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.004]
[7]周 媛,李启注,徐京育.苓桂术甘汤治疗心力衰竭研究进展[J].陕西中医,2022,(12):1819.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.042]
ZHOU Yuan,LI Qizhu,XU Jingyu.Overview of the clinical application of Linggui Zhugan prescription in the treatment of heart failure[J].,2022,(6):1819.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.042]
[8]李 敏,刘福明,邢俊武,等.葶苈大枣泻肺汤合决渎汤治疗心力衰竭阳虚水泛证临床研究[J].陕西中医,2023,(6):721.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.008]
LI Min,LIU Fuming,XING Junwu,et al.Analysis of curative effect of Tingli Dazao Xiefei decoction and Juedu decoction in heart failure with yang deficiency and water flooding syndrome[J].,2023,(6):721.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.008]
[9]陈铭钦,雷瑗琳,师瑞瑞,等.益心附葶饮对慢性心力衰竭心肾阳虚证大鼠HIF-1/VEGF信号通路的影响[J].陕西中医,2023,(11):1527.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.007]
CHEN Mingqin,LEI Yuanlin,SHI Ruirui,et al.Effect of Yixin Futing Yin on HIF-1/VEGF signaling pathway in rats with chronic heart failure of Xinshen Yangxu syndrome[J].,2023,(6):1527.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.007]
[10]曹晓璇,胡佳裕,张钰欣,等.基于“三焦气化”论治老年心力衰竭利尿剂抵抗[J].陕西中医,2023,(11):1585.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.021]